BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 11934683)

  • 1. Regional myocardial blood flow and glucose utilization during fasting and physiological hyperinsulinemia in humans.
    Iozzo P; Chareonthaitawee P; Di Terlizzi M; Betteridge DJ; Ferrannini E; Camici PG
    Am J Physiol Endocrinol Metab; 2002 May; 282(5):E1163-71. PubMed ID: 11934683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mismatch between insulin-mediated glucose uptake and blood flow in the heart of patients with Type II diabetes.
    Iozzo P; Chareonthaitawee P; Rimoldi O; Betteridge DJ; Camici PG; Ferrannini E
    Diabetologia; 2002 Oct; 45(10):1404-9. PubMed ID: 12378381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-induced increment of coronary flow reserve is not abolished by dexamethasone in healthy young men.
    Laine H; Nuutila P; Luotolahti M; Meyer C; Elomaa T; Koskinen P; Rönnemaa T; Knuuti J
    J Clin Endocrinol Metab; 2000 May; 85(5):1868-73. PubMed ID: 10843167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-stimulated myocardial glucose uptake and the relation to perfusion and the nitric oxide system.
    Søndergaard HM; Bøttcher M; Schmitz O; Nielsen TT; Bøtker HE
    J Vasc Res; 2004; 41(1):38-45. PubMed ID: 14726631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of hyperinsulinemia on myocardial fluorine-18-FDG uptake.
    Ng CK; Soufer R; McNulty PH
    J Nucl Med; 1998 Mar; 39(3):379-83. PubMed ID: 9529278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exenatide alters myocardial glucose transport and uptake depending on insulin resistance and increases myocardial blood flow in patients with type 2 diabetes.
    Gejl M; Søndergaard HM; Stecher C; Bibby BM; Møller N; Bøtker HE; Hansen SB; Gjedde A; Rungby J; Brock B
    J Clin Endocrinol Metab; 2012 Jul; 97(7):E1165-9. PubMed ID: 22544917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low myocardial glucose uptake in Turner syndrome is unaffected by growth hormone: a randomized, placebo-controlled FDG-PET study.
    Trolle C; Hjerrild B; Mortensen KH; Knorr S; Søndergaard HM; Christiansen JS; Gravholt CH
    Clin Endocrinol (Oxf); 2015 Jul; 83(1):133-40. PubMed ID: 25645325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [An approach for comparative quantification of myocardial blood flow (O-15-H2O-PET), perfusion (Tc-99m-tetrofosmin-SPECT) and metabolism (F-18-FDG-PET)].
    Schäfer WM; Nowak B; Kaiser HJ; Block S; Koch KC; vom Dahl J; Büll U
    Nuklearmedizin; 2001 Oct; 40(5):164-71. PubMed ID: 11727629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ketone Body Infusion With 3-Hydroxybutyrate Reduces Myocardial Glucose Uptake and Increases Blood Flow in Humans: A Positron Emission Tomography Study.
    Gormsen LC; Svart M; Thomsen HH; Søndergaard E; Vendelbo MH; Christensen N; Tolbod LP; Harms HJ; Nielsen R; Wiggers H; Jessen N; Hansen J; Bøtker HE; Møller N
    J Am Heart Assoc; 2017 Feb; 6(3):. PubMed ID: 28242634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative analysis of myocardial glucose utilization in patients with left ventricular dysfunction by means of 18F-FDG dynamic positron tomography and three-compartment analysis.
    Morita K; Katoh C; Yoshinaga K; Noriyasu K; Mabuchi M; Tsukamoto T; Kageyama H; Shiga T; Kuge Y; Tamaki N
    Eur J Nucl Med Mol Imaging; 2005 Jul; 32(7):806-12. PubMed ID: 15776232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed response of insulin-stimulated fluorine-18 deoxyglucose uptake in glucose transporter-4-null mice hearts.
    Simões MV; Egert S; Ziegler S; Miyagawa M; Reder S; Lehner T; Nguyen N; Charron MJ; Schwaiger M
    J Am Coll Cardiol; 2004 May; 43(9):1690-7. PubMed ID: 15120832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of myocardial glucose uptake in patients with ischemic cardiomyopathy: application of a new quantitative method using regional tracer kinetic information.
    Wiggers H; Bøttcher M; Nielsen TT; Gjedde A; Bøtker HE
    J Nucl Med; 1999 Aug; 40(8):1292-300. PubMed ID: 10450680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heart failure patients with prediabetes and newly diagnosed diabetes display abnormalities in myocardial metabolism.
    Nielsen R; Jorsal A; Iversen P; Tolbod L; Bouchelouche K; Sørensen J; Harms HJ; Flyvbjerg A; Bøtker HE; Wiggers H
    J Nucl Cardiol; 2018 Feb; 25(1):169-176. PubMed ID: 27473218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variability of insulin-stimulated myocardial glucose uptake in healthy elderly subjects.
    Kofoed KF; Hove JD; Freiberg J; Høst U; Holm S; Kelbaek H
    Eur J Nucl Med Mol Imaging; 2002 Dec; 29(12):1600-7. PubMed ID: 12458394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Organ-specific insulin resistance in patients with noninsulin-dependent diabetes mellitus and hypertension.
    Yokoyama I; Ohtake T; Momomura S; Yonekura K; Yamada N; Nishikawa J; Sasaki Y; Omata M
    J Nucl Med; 1998 May; 39(5):884-9. PubMed ID: 9591594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of microsphere-equivalent blood flow (15O-water PET) and relative perfusion (99mTc-tetrofosmin SPECT) in myocardium showing metabolism-perfusion mismatch.
    Schaefer WM; Nowak B; Kaiser HJ; Koch KC; Block S; vom Dahl J; Buell U
    J Nucl Med; 2003 Jan; 44(1):33-9. PubMed ID: 12515874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spatial heterogeneity in fasting and insulin-stimulated (18)F-2-deoxyglucose uptake in pigs with hibernating myocardium.
    Fallavollita JA
    Circulation; 2000 Aug; 102(8):908-14. PubMed ID: 10952961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac and skeletal muscle insulin resistance in patients with coronary heart disease. A study with positron emission tomography.
    Paternostro G; Camici PG; Lammerstma AA; Marinho N; Baliga RR; Kooner JS; Radda GK; Ferrannini E
    J Clin Invest; 1996 Nov; 98(9):2094-9. PubMed ID: 8903329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Similar patterns of myocardial metabolism and perfusion in patients with type 2 diabetes and heart disease of ischaemic and non-ischaemic origin.
    Masi S; Lautamäki R; Guiducci L; Di Cecco P; Porciello C; Pardini S; Morales MA; Chubuchny V; Salvadori PA; Emdin M; Sironi AM; Knuuti J; Neglia D; Nuutila P; Ferrannini E; Iozzo P
    Diabetologia; 2012 Sep; 55(9):2494-500. PubMed ID: 22752026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin resistance in patients with cardiac hypertrophy.
    Paternostro G; Pagano D; Gnecchi-Ruscone T; Bonser RS; Camici PG
    Cardiovasc Res; 1999 Apr; 42(1):246-53. PubMed ID: 10435017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.